Table 4.
Association between the fitness test results and ACE, ACTN3, PPARD, and PPARGC1A polymorphisms
| Genotype | Handgrip strength (kg) | Standing long jump (cm) | 30-s sit-up (counts) | 60-s sit-up (counts) | 60-m dash (s) | 800-m run (s) |
|---|---|---|---|---|---|---|
| ACE | ||||||
| DD (n = 12) | 28.3 ± 1.2 | 152.6 ± 6.1 | 18.0 ± 1.2 | 32.3 ± 2.3 | 11.6 ± 0.4 | 290.1 ± 10.0 |
| ID (n = 74) | 25.0 ± 0.5 | 144.5 ± 2.5 | 17.5 ± 0.5 | 31.6 ± 1.0 | 11.9 ± 0.2 | 287.2 ± 4.1 |
| II (n = 84) | 25.7 ± 0.5 | 146.0 ± 2.3 | 18.0 ± 0.4 | 32.0 ± 0.9 | 11.8 ± 0.1 | 281.7 ± 3.8 |
| p value | 0.048 | 0.421 | 0.734 | 0.941 | 0.649 | 0.535 |
| ACTN3 | ||||||
| RR (n = 46) | 26.7 ± 0.6 | 143.8 ± 3.2 | 18.7 ± 0.5 | 34.1 ± 1.2 | 12.1 ± 0.2 | 285.2 ± 5.2 |
| RX (n = 90) | 25.1 ± 0.5 | 145.9 ± 2.2 | 17.0 ± 0.4 | 30.3 ± 0.8 | 11.7 ± 0.1 | 285.1 ± 3.7 |
| XX (n = 34) | 25.3 ± 0.8 | 147.5 ± 3.7 | 18.3 ± 0.7 | 32.8 ± 1.4 | 11.7 ± 0.2 | 282.8 ± 6.1 |
| p value | 0.141 | 0.751 | 0.048 | 0.029 | 0.355 | 0.940 |
| PPARD | ||||||
| TT (n = 65) | 25.6 ± 0.5 | 144.5 ± 2.5 | 17.6 ± 0.5 | 31.7 ± 1.0 | 11.9 ± 0.2 | 281.6 ± 4.3 |
| TC (n = 77) | 25.6 ± 0.5 | 150.1 ± 2.4 | 17.8 ± 0.5 | 31.8 ± 0.9 | 11.6 ± 0.1 | 283.8 ± 4.0 |
| CC (n = 28) | 25.5 ± 0.8 | 136.9 ± 4.0 | 18.0 ± 0.8 | 32.2 ± 1.6 | 12.1 ± 0.2 | 294.4 ± 6.7 |
| p value | 0.996 | 0.018 | 0.930 | 0.969 | 0.158 | 0.274 |
| PPARGC1A | ||||||
| Ser/Ser (n = 31) | 25.8 ± 0.8 | 146.9 ± 3.8 | 18.3 ± 0.7 | 32.9 ± 1.4 | 11.7 ± 0.2 | 288.6 ± 6.2 |
| Gly/Ser (n = 98) | 25.4 ± 0.4 | 146.4 ± 2.1 | 17.3 ± 0.4 | 30.5 ± 0.8 | 11.8 ± 0.1 | 284.9 ± 3.5 |
| Gly/Gly (n = 41) | 26.2 ± 0.7 | 144.1 ± 3.4 | 18.7 ± 0.6 | 34.4 ± 1.3 | 11.9 ± 0.2 | 281.2 ± 5.6 |
| p value | 0.589 | 0.825 | 0.126 | 0.026 | 0.652 | 0.675 |
Values expressed as mean ± SE adjusted for height, body weight, BMI, FFM%, FFM, and FFMI by ANCOVA
The bold values indicate that there is a significant difference in the Bonferroni post hoc test